Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients

NCT05503030 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Diseases, Interstitial

Interventions

DRUG: Nintedanib

Sponsor

Boehringer Ingelheim